Frazier Life Sciences VIII, L.P.

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Frazier Life Sciences VIII, L.P.'s trades of Arcutis Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
73.71
Quantity 6,998 -40.7%
Value US$2,190,111
Transaction date
Purchase
Price
387.21
Quantity 32,036 +6.6%
Value US$2,262,274
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-26 2023-10-24
B Purchase
6,998 -40.7%
73.71
US$2,190,111 		6,998 -40.7% 73.71 US$2,190,111
2022-08-09 2022-08-05
B Purchase
32,036 +6.6%
387.21
US$2,262,274 		32,036 +6.6% 387.21 US$2,262,274
2022-02-15 2022-02-11
B Purchase
74,155 -35.0%
18.61
US$4,665,861 		74,155 -35.0% 18.61 US$4,665,861
2020-02-06 2020-02-04
B Purchase
500,000 +5.0%
17.00
US$8,500,000 		500,000 +5.0% 17.00 US$8,500,000
2020-01-13 2020-01-09
S Sale
50,000 -3.7%
5.00
US$250,010 		50,000 -3.7% 5.00 US$250,010
2019-01-22 2019-01-18
B Purchase
372,439 +16.9%
5.37
US$1,999,997 		372,439 +16.9% 5.37 US$1,999,997